£60.00
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to increase the natural production of growth hormone (GH). It is FDA-approved for the treatment of HIV-associated lipodystrophy, a condition characterized by excessive abdominal fat accumulation.
Reduces visceral fat (especially in HIV patients)
Enhances natural GH production
Supports muscle growth and metabolism
May improve cognitive function and cardiovascular health
Potential anti-aging effects
Tesamorelin mimics the action of natural GHRH by binding to GHRH receptors in the pituitary gland, leading to increased GH and insulin-like growth factor-1 (IGF-1) levels. Unlike direct GH administration, Tesamorelin preserves the body’s natural GH secretion patterns.
Recommended dose: 2 mg per day via subcutaneous injection
Usually administered in the abdomen
Treatment duration varies based on clinical or research applications
Mild injection site reactions (redness, swelling)
Increased appetite
Water retention
Joint pain
Possible insulin resistance with prolonged use
Tesamorelin is primarily prescribed for medical use but is also studied for its potential in anti-aging and body composition improvements. Always consult a medical professional before use.